Suzhou Basecare Medical Corporation Limited (HKG:2170)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.265
+0.025 (2.02%)
Oct 2, 2026, 1:17 PM HKT

HKG:2170 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-174.03-223.46-237.03-191.69-122.66-143.65
Depreciation & Amortization
44.8848.3535.6619.538.395.59
Other Amortization
0.010.010.020.04--
Loss (Gain) From Sale of Assets
-0.44-0.440.660.18-8.7-0
Loss (Gain) From Sale of Investments
10.7210.72-2.92.4-3.4-
Stock-Based Compensation
-----7.91
Provision & Write-off of Bad Debts
4.874.8718.56---
Other Operating Activities
-3.433.26-27.85-55.65-89.9611.27
Change in Accounts Receivable
-36.19-36.197.562.14-15.07-46.89
Change in Inventory
-9.89-9.893.94-21.15-14.74-24.1
Change in Accounts Payable
32.5132.51-52.42-22.3930.187.75
Change in Unearned Revenue
1.641.6424.82-1.572-
Change in Other Net Operating Assets
0.740.74-0.140.9215.73-15.73
Operating Cash Flow
-128.6-167.88-229.12-267.23-188.77-197.85
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-35.54-85.57-93.3-104.21-128.45-28.9
Sale of Property, Plant & Equipment
-1.910.581.540.880.080.36
Cash Acquisitions
----257.89-32.51-42.48
Divestitures
----3.2453.6-
Sale (Purchase) of Intangibles
-----0.06-
Investment in Securities
-83.77-111.88---
Other Investing Activities
8.849.3522.4439.6418.6514.42
Investing Cash Flow
-28.68.12-181.19-324.81-88.7-56.6

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-47.2490.14196.7449.7543.65
Total Debt Issued
39.2347.2490.14196.7449.7543.65
Long-Term Debt Repaid
--30.56-44.85-4.79-23.15-32.63
Lease Payments
-2.1-3.45-5.14-4.79-3.15-2.63
Total Debt Repaid
-36.53-30.56-44.85-4.79-23.15-32.63
Net Debt Issued (Repaid)
2.716.6745.3191.9526.611.01
Issuance of Common Stock
-----1,678
Other Financing Activities
-11.25-12.85-11.52-1.4-3.09-93.69
Financing Cash Flow
-8.553.8233.78190.5523.511,596

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-4.31-1.916.0612.5762.91-10.31
Net Cash Flow
-170.06-157.84-370.47-388.93-191.051,331

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-164.14-253.45-322.41-371.44-317.22-226.75
Free Cash Flow Growth
------
Free Cash Flow Margin
-62.97%-108.65%-107.79%-178.60%-225.14%-211.33%
Free Cash Flow Per Share
-0.60-0.93-1.18-1.36-1.16-0.85
Levered Free Cash Flow
-139.54-225.97-267.63-244.92-195.9-160.63
Unlevered Free Cash Flow
-132.46-217.77-261.77-243.28-195.59-159.84
Free Cash Flow After Leases
-166.23-256.9-327.55-376.23-320.37-229.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-0.110.470.240.190.24
Cash Income Tax Paid
0.450.44-0.023.26--
Change in Working Capital
-11.19-11.19-16.25-42.0518.1-78.96